Medication info
Pitavastatin Calcium Hydrate Tablet 2 mg

Pitavastatin Calcium Hydrate Tablet 2 mg

Prescription medicationTabletOral
Ingredient · strength
Pitavastatin Calcium Hydrate›2mg / 1 tablet
Manufacturer / importer
Geonil Biopharm Co., Ltd.
Appearance
Very pale yellowish-red, round film-coated tablets
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201903527 · Approved 2019.05.29 · Insurance code 073000180

Summary

Main use
Improvement of primary hypercholesterolemia and mixed dyslipidemia
Who takes it
Adults
Adult dose
Patients must follow a standard cholesterol-lowering diet before and during treatment with this drug. The usual initial dose for adults is 1–2 mg of pitavastatin calcium once daily. If the reduction in LDL cholesterol is insufficient, the dose may be increased to a maximum of 4 mg daily. Adjust the dose as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and patient response. The therapeutic effect of this drug is maintained with continued administration.

Ingredients

Manufacturer
Geonil Biopharm Co., Ltd.

Efficacy & effects

Improvement of primary hypercholesterolemia and mixed dyslipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed dyslipidemia
  • elevated total cholesterol
  • LDL cholesterol
  • apolipoprotein B
  • and triglycerides
View approved original text

This medication helps control abnormal lipid levels in patients with primary hypercholesterolemia and mixed dyslipidemia. It lowers total cholesterol, LDL cholesterol, apolipoprotein B, and triglyceride levels while increasing the levels of HDL cholesterol, often referred to as good cholesterol. When used in conjunction with dietary therapy, it is effective in managing blood lipids and contributes to reducing the risk of cardiovascular disease. This medication is used for improving the health of individuals with dyslipidemia.

How to take

Adult dose

Patients must follow a standard cholesterol-lowering diet before and during treatment with this drug. The usual initial dose for adults is 1–2 mg of pitavastatin calcium once daily. If the reduction in LDL cholesterol is insufficient, the dose may be increased to a maximum of 4 mg daily. Adjust the dose as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and patient response. The therapeutic effect of this drug is maintained with continued administration.

Precautions

This medication should not be used in certain patients. For example, patients who are allergic to this medication or have active liver disease, severe liver impairment, or are pregnant or breastfeeding should not take this medication. Additionally, it is not used in children as its safety has not been established. Patients with renal dysfunction or a history of liver impairment should use this medication with caution, and there is an increased risk of muscle damage when taken with certain other medications, necessitating careful monitoring. In particular, concomitant use with fibrates or niacin may lead to muscle issues and renal deterioration, making it advisable to avoid such combinations. During treatment with this medication, unusual symptoms such as muscle pain, muscle weakness, dizziness, dyspepsia, and skin rash may occur. If muscle-related symptoms or liver dysfunction symptoms arise, immediate consultation with a physician is required, and the medication should be discontinued if necessary. Regular liver function tests should be conducted, and treatment should be halted if enzyme levels rise, with appropriate measures taken. Additionally, this medication may cause thrombocytopenia or other blood abnormalities, hence periodic testing is needed. This medication is used for the treatment of hypercholesterolemia, and it is recommended to attempt non-pharmacological treatments such as diet and exercise before starting medication. It's also important to regularly check blood lipid levels during treatment to assess therapeutic effectiveness; if it is ineffective, the medication should be discontinued. Pregnant women or those who may become pregnant should not take this medication due to potential harm to the fetus, and breastfeeding women should also avoid its use. There is insufficient data on the safety of this medication for children, so it is not used in pediatric patients. Store the medication out of reach of children, in its original container to prevent degradation of quality. Elderly patients may experience adverse effects more readily due to decreased physical function, so caution is needed and dosage adjustments may be necessary if unusual symptoms manifest. Lastly, this medication may interact with certain drugs, so it is essential to consult with a physician or pharmacist if other medications are being taken.

Side effects

  • Abdominal pain
  • rash
  • malaise
  • paralysis
  • itching
  • myalgia
  • weakness
  • elevated CPK levels
  • increased myoglobin in blood and urine
  • acute renal failure
Show 82 more
  • liver dysfunction
  • jaundice
  • thrombocytopenia
  • urticaria
  • erythema
  • angioedema
  • elevated bilirubin
  • increased cholinesterase
  • elevated AST
  • elevated ALT
  • increased γ-GT
  • elevated ALP
  • elevated LDH
  • stiffness
  • drowsiness
  • insomnia
  • headache
  • heaviness in the head
  • dizziness
  • dry mouth
  • dyspepsia
  • abdominal distension
  • constipation
  • stomatitis
  • vomiting
  • loss of appetite
  • glossitis
  • nausea
  • gastric discomfort
  • diarrhea
  • agranulocytosis
  • leukopenia
  • eosinophilia
  • leukocytosis
  • elevated globulin
  • positive Coombs test
  • anemia
  • polyuria
  • elevated BUN
  • increased serum creatinine
  • decreased aldosterone
  • increased aldosterone
  • elevated adrenocorticotropic hormone
  • increased cortisol
  • decreased testosterone
  • muscle cramps
  • feeling of weakness
  • palpitations
  • fatigue
  • dermalgia
  • burning sensation
  • arthralgia
  • edema
  • blurred vision
  • photophobia
  • hearing loss
  • hematuria
  • elevated uric acid levels
  • increased serum potassium and phosphorus
  • taste disturbances
  • positive antinuclear antibody
  • sleep disorders
  • memory loss
  • depression
  • interstitial lung disease
  • sexual dysfunction
  • diabetes
  • immune-mediated necrotizing myopathy
  • myasthenia gravis
  • ocular myasthenia
  • facial edema
  • arm edema
  • hypersensitivity
  • headache
  • dizziness
  • skin tingling
  • insomnia
  • loss of appetite
  • elevated blood pressure
  • chest discomfort
  • weakness
  • nausea

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light and should be stored in a container that does not allow light exposure. Additionally, it should be stored at room temperature between 1 and 30 degrees Celsius for safe use.

Appearance and packaging

Appearance

Very pale yellowish-red, round film-coated tablets

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.